Matches in SemOpenAlex for { <https://semopenalex.org/work/W2160148379> ?p ?o ?g. }
- W2160148379 endingPage "316" @default.
- W2160148379 startingPage "309" @default.
- W2160148379 abstract "A phase III clinical study was carried out among 534 fertile Latin American women to evaluate cycle control, side effects, and contraceptive efficacy of a once-a-month combined injectable, Mesigyna, consisting of 50 mg norethisterone enanthate and 5 mg estradiol valerate. The pregnancy rate at 1 year was 0 per 100 woman-years for a total experience of 4688 woman-months. The overall discontinuation rate at one year was 17.9%. Discontinuation rate for bleeding problems was 5.1%. The Colombian women had a significant increase (p <0.001) in bleeding problems compared to other countries. The discontinuation rate for amenorrhea was 1.1%. There were no significant differences between the groups regarding discontinuation for other medical or non-medical reasons. Mean weight gain after one year of use was 1.02 kg. Mesigyna is an appropiate once-a-month injectable contraceptive for Latin American women since it is highly effective and its perception of normal menstrual bleeding is of importance in the Latin American population." @default.
- W2160148379 created "2016-06-24" @default.
- W2160148379 creator A5003706121 @default.
- W2160148379 creator A5005245490 @default.
- W2160148379 creator A5012220305 @default.
- W2160148379 creator A5012640419 @default.
- W2160148379 creator A5013791794 @default.
- W2160148379 creator A5015686178 @default.
- W2160148379 creator A5018958309 @default.
- W2160148379 creator A5025334985 @default.
- W2160148379 creator A5028391513 @default.
- W2160148379 creator A5032367496 @default.
- W2160148379 creator A5040322635 @default.
- W2160148379 creator A5045909333 @default.
- W2160148379 creator A5048188586 @default.
- W2160148379 creator A5051994130 @default.
- W2160148379 creator A5058064690 @default.
- W2160148379 creator A5058117410 @default.
- W2160148379 creator A5059006415 @default.
- W2160148379 creator A5059715726 @default.
- W2160148379 creator A5060112547 @default.
- W2160148379 creator A5061935451 @default.
- W2160148379 creator A5063363095 @default.
- W2160148379 creator A5067416718 @default.
- W2160148379 creator A5069281332 @default.
- W2160148379 creator A5075350547 @default.
- W2160148379 creator A5075683061 @default.
- W2160148379 creator A5076130199 @default.
- W2160148379 creator A5078678223 @default.
- W2160148379 creator A5080771071 @default.
- W2160148379 creator A5083905627 @default.
- W2160148379 creator A5084803558 @default.
- W2160148379 creator A5085449026 @default.
- W2160148379 creator A5090924930 @default.
- W2160148379 creator A5091036017 @default.
- W2160148379 date "2000-05-01" @default.
- W2160148379 modified "2023-10-14" @default.
- W2160148379 title "Mesigyna® once-a-month combined injectable contraceptive: Experience in Latin America" @default.
- W2160148379 cites W1740052826 @default.
- W2160148379 cites W185624980 @default.
- W2160148379 cites W2024785495 @default.
- W2160148379 cites W2048033256 @default.
- W2160148379 cites W2057398384 @default.
- W2160148379 cites W2075276906 @default.
- W2160148379 cites W2084035275 @default.
- W2160148379 cites W2089158466 @default.
- W2160148379 cites W2122406834 @default.
- W2160148379 cites W2171404744 @default.
- W2160148379 cites W2615672635 @default.
- W2160148379 doi "https://doi.org/10.1016/s0010-7824(00)00109-8" @default.
- W2160148379 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10906501" @default.
- W2160148379 hasPublicationYear "2000" @default.
- W2160148379 type Work @default.
- W2160148379 sameAs 2160148379 @default.
- W2160148379 citedByCount "14" @default.
- W2160148379 countsByYear W21601483792014 @default.
- W2160148379 countsByYear W21601483792020 @default.
- W2160148379 countsByYear W21601483792021 @default.
- W2160148379 crossrefType "journal-article" @default.
- W2160148379 hasAuthorship W2160148379A5003706121 @default.
- W2160148379 hasAuthorship W2160148379A5005245490 @default.
- W2160148379 hasAuthorship W2160148379A5012220305 @default.
- W2160148379 hasAuthorship W2160148379A5012640419 @default.
- W2160148379 hasAuthorship W2160148379A5013791794 @default.
- W2160148379 hasAuthorship W2160148379A5015686178 @default.
- W2160148379 hasAuthorship W2160148379A5018958309 @default.
- W2160148379 hasAuthorship W2160148379A5025334985 @default.
- W2160148379 hasAuthorship W2160148379A5028391513 @default.
- W2160148379 hasAuthorship W2160148379A5032367496 @default.
- W2160148379 hasAuthorship W2160148379A5040322635 @default.
- W2160148379 hasAuthorship W2160148379A5045909333 @default.
- W2160148379 hasAuthorship W2160148379A5048188586 @default.
- W2160148379 hasAuthorship W2160148379A5051994130 @default.
- W2160148379 hasAuthorship W2160148379A5058064690 @default.
- W2160148379 hasAuthorship W2160148379A5058117410 @default.
- W2160148379 hasAuthorship W2160148379A5059006415 @default.
- W2160148379 hasAuthorship W2160148379A5059715726 @default.
- W2160148379 hasAuthorship W2160148379A5060112547 @default.
- W2160148379 hasAuthorship W2160148379A5061935451 @default.
- W2160148379 hasAuthorship W2160148379A5063363095 @default.
- W2160148379 hasAuthorship W2160148379A5067416718 @default.
- W2160148379 hasAuthorship W2160148379A5069281332 @default.
- W2160148379 hasAuthorship W2160148379A5075350547 @default.
- W2160148379 hasAuthorship W2160148379A5075683061 @default.
- W2160148379 hasAuthorship W2160148379A5076130199 @default.
- W2160148379 hasAuthorship W2160148379A5078678223 @default.
- W2160148379 hasAuthorship W2160148379A5080771071 @default.
- W2160148379 hasAuthorship W2160148379A5083905627 @default.
- W2160148379 hasAuthorship W2160148379A5084803558 @default.
- W2160148379 hasAuthorship W2160148379A5085449026 @default.
- W2160148379 hasAuthorship W2160148379A5090924930 @default.
- W2160148379 hasAuthorship W2160148379A5091036017 @default.
- W2160148379 hasConcept C126322002 @default.
- W2160148379 hasConcept C131872663 @default.
- W2160148379 hasConcept C141071460 @default.
- W2160148379 hasConcept C2777902738 @default.
- W2160148379 hasConcept C2778001906 @default.
- W2160148379 hasConcept C2778058571 @default.